What is the name of the drug satelizumab (Anshiping) in China?

The original drug Satralizumab (Satralizumab) has been launched in China and is included in medical insurance. Its generic name is Satralizumab and its brand name is Anshiping. Satelizumab is a drug used to treat patients 12 years and older with neuromyelitis optica spectrum disorder (NMOSD), an inflammatory disease that primarily affects the optic nerve (the nerve that connects the eye to the brain) and spinal cord. This results in impaired vision, loss of sensation, bladder control, weakness in the limbs, and paralysis. Patients should begin treatment with this drug under the supervision of a physician experienced in treating neuromyelitis optica spectrum disorders, and this drug is available by prescription only.